View Item 

Show simple item record

Implications of Research Biopsies in Clinical Trials
dc.contributor.authorDermody, Sarah M.
dc.contributor.authorShuman, Andrew G.
dc.date.accessioned2022-01-06T15:51:12Z
dc.date.available2023-01-06 10:51:11en
dc.date.available2022-01-06T15:51:12Z
dc.date.issued2021-12
dc.identifier.citationDermody, Sarah M.; Shuman, Andrew G. (2021). "Implications of Research Biopsies in Clinical Trials." The Oncologist 26(12): 994-996.
dc.identifier.issn1083-7159
dc.identifier.issn1549-490X
dc.identifier.urihttps://hdl.handle.net/2027.42/171221
dc.publisherJohn Wiley & Sons, Inc.
dc.titleImplications of Research Biopsies in Clinical Trials
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelHematology and Oncology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/171221/1/onco13948_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/171221/2/onco13948.pdf
dc.identifier.doi10.1002/onco.13948
dc.identifier.sourceThe Oncologist
dc.identifier.citedreferenceSpector‐Bagdady K, Krenz CD, Brummel C et al. “ My research is their business, but i’m not their business”: Patient and clinician perspectives on commercialization of precision oncology data. The Oncologist 2020; 25: 620 – 626.
dc.identifier.citedreferenceArneth B. Update on the types and usage of liquid biopsies in the clinical setting: A systematic review. BMC Cancer 2018; 18: 527.
dc.identifier.citedreferenceEl‐Osta H, Hong D, Wheler J et al. Outcomes of research biopsies in phase I clinical trials: MD Anderson Cancer Center experience. The Oncologist 2011; 16: 1292 – 1298.
dc.identifier.citedreferenceBai R, Lv Z, Xu D et al. Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors. Biomark Res 2020; 8: 34.
dc.identifier.citedreferenceGavrielatou N, Doumas S, Economopoulou P et al. Biomarkers for immunotherapy response in head and neck cancer. Cancer Treat Rev 2020; 84: 101977.
dc.identifier.citedreferenceSulmasy DP, Astrow AB, He MK et al. The culture of faith and hope: Patients’ justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials. Cancer 2010; 116: 3702 – 3711.
dc.identifier.citedreferencedel Carmen MG, Joffe S. Informed consent for medical treatment and research: A review. The Oncologist 2005; 10: 636 – 641.
dc.identifier.citedreferenceHenderson GE, Churchill LR, Davis AM et al. Clinical trials and medical care: Defining the therapeutic misconception. PLoS Med 2007; 4: e324.
dc.identifier.citedreferencePentz RD, Harvey RD, White M et al. Research biopsies in phase I studies: Views and perspectives of participants and investigators. IRB 2012; 34: 1 – 8.
dc.identifier.citedreferenceLidz CW, Appelbaum PS. The therapeutic misconception: Problems and solutions. Med Care 2002; 40 ( suppl 9 ): V55 – 63.
dc.identifier.citedreferenceSpector‐Bagdady K, De Vries RG, Gornick MG et al. Encouraging participation and transparency in biobank research. Health Aff (Millwood) 2018; 37: 1313 – 1320.
dc.identifier.citedreferenceAlix‐Panabières C. The future of liquid biopsy. Nature 2020; 579: S9.
dc.identifier.citedreferenceOverman MJ, Modak J, Kopetz S et al: Use of research biopsies in clinical trials: Are risks and benefits adequately discussed? J Clin Oncol 2013; 31: 17 – 22.
dc.identifier.citedreferenceLevit LA, Peppercorn JM, Tam AL et al. Ethical framework for including research biopsies in oncology clinical trials: American Society of Clinical Oncology research statement. J Clin Oncol 2019; 37: 2368 – 2377.
dc.identifier.citedreferenceOlympios N, Collet L, Paesmans M et al. Analyses of the rationale and implementation of research biopsies in oncology clinical trials at a tertiary cancer center. The Oncologist 2021 [epub ahead of print].
dc.identifier.citedreferenceAnderson BD, Adamson PC, Weiner SL et al. Tissue collection for correlative studies in childhood cancer clinical trials: Ethical considerations and special imperatives. J Clin Oncol 2004; 22: 4846 – 4850.
dc.identifier.citedreferenceKimmelman J, Resnik DB, Peppercorn J et al: Burdensome research procedures in trials: Why less is more. J Natl Cancer Inst 2017; 109:djw315.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
onco13948_am.pdf
Size:
457.2KB
Format:
PDF
View/Open
Name:
onco13948.pdf
Size:
220.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.